Lytx-Pa2a is a peptide inhibitor that targets bacterial cell membranes (bacterialmembranes) and the TLR4 receptor (TLR4receptor). It exhibits antibacterial effects by non-competitively disrupting extracellular/cytoplasmic membranes and inhibits the LPS-induced TLR4/NF-kappaB signaling pathway. Lytx-Pa2a holds potential for research in bacterial infections and inflammation-related diseases, such as sepsis.
Target:
TLR|||Antibacterial
* VAT and and shipping costs not included. Errors and price changes excepted
